Cargando…
Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia
Although cure rates for pediatric acute lymphoblastic leukemia (ALL) have now risen to more than 90%, subsets of patients with high-risk features continue to experience high rates of treatment failure and relapse. Recent work in minimal residual disease stratification and leukemia genomics have incr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268159/ https://www.ncbi.nlm.nih.gov/pubmed/32537116 http://dx.doi.org/10.1177/2040620720927575 |